17
Jul-2019

Rapid Dose Therapeutics signs distribution agreement for Quickstrip™ Nutraceutical product line

Innovation Factory Client, Rapid Dose Therapeutics is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes.  Learn more about their company at www.rapid-dose.com


July 16, 2019

Rapid Dose Therapeutics Corp. and Ukraine Pharma announced today that they have signed a twelve month distribution  agreement (the “Agreement”) to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European countries, giving the Company rights to market the Energy, B12, and Sleep QuickStrip™ nutraceutical products to a consumer base of over 200 million people with tremendous buying power.

The Agreement requires a minimum quarterly order of one million of each of RDT’s Energy, B12, and Sleep QuickStrips™ and the Company has provided RDT with a signed purchase order for US$2.1 million.

RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers an Anytime, Anywhere™ product to consumers. Ukraine Pharma expects to distribute QuickStrip™ by the third calendar quarter of 2019.

Read the full press release here.


This press release originally appeared on Rapid Dose Therapeutics’ homepage.  For more information on Rapid Dose and for the full release please visit their website at www.rapid-dose.com 

Share this post: